An Extension of the CONCERT Protocol (DIM18)

A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease

NCT00912288 ·Status: TERMINATED ·Phase: PHASE3

A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease

NCT00838110 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil

NCT00829816 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin

NCT00990613 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease

NCT00675623 ·Status: COMPLETED ·Phase: PHASE3

A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects

NCT00825084 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

NCT00824590 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia

NCT07251023 ·Status: RECRUITING ·Phase: PHASE3

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease

NCT00551161 ·Status: COMPLETED ·Phase: PHASE4

A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

NCT00827034 ·Status: COMPLETED ·Phase: PHASE1

Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

NCT00704782 ·Status: TERMINATED ·Phase: PHASE2

Brain Imaging and Mental Disorders of Aging Intervention

NCT00267163 ·Status: COMPLETED ·Phase: PHASE4

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease

NCT01082965 ·Status: TERMINATED ·Phase: NA

Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)

NCT00523666 ·Status: UNKNOWN ·Phase: PHASE4

A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease

NCT01066481 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

NCT03114657 ·Status: TERMINATED ·Phase: PHASE3

A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease

NCT02353598 ·Status: COMPLETED ·Phase: PHASE1

Metformin in Alzheimer's Dementia Prevention

NCT04098666 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease

NCT00377715 ·Status: COMPLETED ·Phase: PHASE2

Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease

NCT03090516 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

NCT00293176 ·Status: COMPLETED ·Phase: PHASE4

Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease

NCT05267535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

NCT07169630 ·Status: RECRUITING ·Phase: PHASE1

Multicenter Evaluation of Memory Remediation After TBI With Donepezil

NCT02255799 ·Status: COMPLETED ·Phase: PHASE3